0000849146-21-000068.txt : 20210816 0000849146-21-000068.hdr.sgml : 20210816 20210816160656 ACCESSION NUMBER: 0000849146-21-000068 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20210812 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20210816 DATE AS OF CHANGE: 20210816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lifevantage Corp CENTRAL INDEX KEY: 0000849146 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841097796 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35647 FILM NUMBER: 211178035 BUSINESS ADDRESS: STREET 1: 3300 TRIUMPH BLVD STREET 2: SUITE 700 CITY: LEHI STATE: UT ZIP: 84043 BUSINESS PHONE: 801-432-9000 MAIL ADDRESS: STREET 1: 3300 TRIUMPH BLVD STREET 2: SUITE 700 CITY: LEHI STATE: UT ZIP: 84043 FORMER COMPANY: FORMER CONFORMED NAME: LIFELINE THERAPEUTICS, INC. DATE OF NAME CHANGE: 20041019 FORMER COMPANY: FORMER CONFORMED NAME: YAAK RIVER RESOURCES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ANDRAPLEX CORP DATE OF NAME CHANGE: 19920406 8-K 1 lfvn-20210812.htm 8-K lfvn-20210812
0000849146false00008491462020-09-032020-09-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ______________________________
 FORM 8-K
 ______________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 12, 2021
 ______________________________
LIFEVANTAGE CORPORATION
(Exact name of registrant as specified in its charter)
______________________________
Delaware001-3564790-0224471
(State or other jurisdiction of
incorporation or organization)		(Commission File Number)(IRS Employer
Identification No.)
3300 Triumph Blvd, Suite 700
Lehi, Utah 84043
(Address of principal executive offices, including zip code)
(801) 432-9000
(Registrant's telephone number)
_____________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Common Stock, par value $0.0001LFVNThe Nasdaq Stock Market LLC
Title of each classTrading Symbol(s)Name of each exchange on which registered
Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b)
On August 12, 2021, Vinayak Hegde, a member of the Board of Directors (the “Board”) of LifeVantage Corporation (the “Company”), informed the Company that, due to his other commitments, he has decided not to stand for re-election as a director of the Company at the fiscal 2022 annual meeting of stockholders expected to be held on or about November 11, 2021. Mr. Hegde’s decision not to stand for re-election was not the result of any disagreements with the Company on matters related to its operations, policies or practices.

SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date:
August 16, 2021
LIFEVANTAGE CORPORATION
By:
/s/ Steven R. Fife
Name:
Steven R. Fife
Title:
President, Chief Executive Officer and Chief Financial Officer


 EX-101.SCH 2 lfvn-20210812.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 lfvn-20210812_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document Type Document Type Entity Address, Postal Zip Code Entity Address, Postal Zip Code Local Phone Number Local Phone Number Written Communications Written Communications City Area Code City Area Code Amendment Flag Amendment Flag Title of 12(b) Security Title of 12(b) Security Entity Address, State or Province Entity Address, State or Province Security Exchange Name Security Exchange Name Soliciting Material Soliciting Material Document Period End Date Document Period End Date Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Cover [Abstract] Cover [Abstract] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line Two Entity Address, Address Line Two Entity Emerging Growth Company Entity Emerging Growth Company Entity Registrant Name Entity Registrant Name Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key Trading Symbol Trading Symbol EX-101.PRE 4 lfvn-20210812_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 5 lfvn-20210812_htm.xml IDEA: XBRL DOCUMENT 0000849146 2020-09-03 2020-09-03 0000849146 false 8-K 2021-08-12 LIFEVANTAGE CORP DE 001-35647 90-0224471 3300 Triumph Blvd Suite 700 Lehi UT 84043 801 432-9000 false false false false Common Stock, par value $0.0001 LFVN NASDAQ false XML 6 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover Page
Sep. 03, 2020
Cover [Abstract]  
Document Type 8-K
Document Period End Date Aug. 12, 2021
Entity Registrant Name LIFEVANTAGE CORP
Entity Central Index Key 0000849146
Amendment Flag false
Entity Incorporation, State or Country Code DE
Entity File Number 001-35647
Entity Tax Identification Number 90-0224471
Entity Address, Address Line One 3300 Triumph Blvd
Entity Address, Address Line Two Suite 700
Entity Address, City or Town Lehi
Entity Address, State or Province UT
Entity Address, Postal Zip Code 84043
City Area Code 801
Local Phone Number 432-9000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001
Trading Symbol LFVN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.lifevantage.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports lfvn-20210812.htm lfvn-20210812.xsd lfvn-20210812_lab.xml lfvn-20210812_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "lfvn-20210812.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "lfvn-20210812.htm" ] }, "labelLink": { "local": [ "lfvn-20210812_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "lfvn-20210812_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "lfvn-20210812.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "lfvn", "nsuri": "http://www.lifevantage.com/20210812", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lfvn-20210812.htm", "contextRef": "ib52350eb7e2943fd81448869dab6cb36_D20200903-20200903", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.lifevantage.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lfvn-20210812.htm", "contextRef": "ib52350eb7e2943fd81448869dab6cb36_D20200903-20200903", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0000849146-21-000068-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000849146-21-000068-xbrl.zip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